Home Comparison of four automated serum vitamin B12 assays
Article
Licensed
Unlicensed Requires Authentication

Comparison of four automated serum vitamin B12 assays

  • Emre İspir EMAIL logo , Muhittin A. Serdar , Taner Ozgurtas , Ozlem Gulbahar , Kadir Okhan Akın , Fatih Yesildal and İsmail Kurt
Published/Copyright: January 20, 2015

Abstract

Background: Diagnosis of vitamin B12 deficiency is generally based on the measurement of serum vitamin B12 levels. However, in selected cases functional indices of vitamin B12, such as methylmalonic acid (MMA) and homocysteine (HCY), are needed. Here we compare the performance of four automated total vitamin B12 assays and also investigate how these assays relate to functional indices of vitamin B12 status.

Methods: Total vitamin B12, MMA and HCY were measured in 69 serum samples from routine vitamin B12 assay requests. Serum vitamin B12 analysis was performed using four different immunoassay autoanalyzers: DxI 800 Unicel (Beckman Coulter, USA), ADVIA Centaur XP (Siemens Diagnostics, Tarrytown, NY, USA), Roche Cobas E601 (Roche Diagnostics, Germany), Architect i2000sr (Abbott Laboratories, Abbott Park, IL, USA). Serum MMA levels were determined by liquid chromatography-mass spectrometry (LC-MS) and serum homocysteine levels were determined by high pressure liquid chromatography (HPLC) methods.

Results: Four immunoassay methods were comparable and correlated with each other. Correlation coefficients (r) ranged from 0.898 to 0.987, p<0.001. Highest correlation was observed between Roche Cobas – Architect i2000sr and poorest correlation was observed between DxI 800 Unicel – ADVIA Centaur comparison. DxI 800 Unicel assay demonstrated high mean bias [–122 pg/mL (–616–125 pg/mL)] and a concordance correlation coefficient (CCC) of 0.9161, lower than the others. MMA and HCY were correlated with the vitamin B12 results. The correlation coefficients with their 95% CI indicated that there was no statistically significant difference between the four methods according to their relationship with MMA and HCY.

Conclusions: Total B12 assays correlate very well with each other. However, results of DxI 800 Unicel were lower compared to the other three autoanalyzers. All total vitamin B12 methods show similar relationships with HCY and MMA. Standardization of serum vitamin B12 assays is still not completed and further standardization studies are needed. Laboratory professionals and clinicians should be aware of this disagreement between assay methods and they should use these tests as ancillary tests.


Corresponding author: Emre İspir, Laboratory Specialist, MD, Hakkari Military Hospital, Department of Medical Biochemistry, Hakkari, Turkey, Phone: +90 04382114868, E-mail:

References

1. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006;5:949–60.10.1016/S1474-4422(06)70598-1Search in Google Scholar

2. Ihara H, Hashizume N, Totani M, Inage H, Kimura S, Nagamura Y, et al. Traditional reference values for serum vitamin B12 and folate are not applicable to automated serum vitamin B12 and folate assays: comparison of value from three automated serum vitamin B12 and folate assays. J Anal Bio Sci 2008;31:291–8.Search in Google Scholar

3. Vogeser M, Lorenzl S. Comparison of automated assays for the determination of vitamin B12 in serum. Clin Biochem 2007;40:1342–5.10.1016/j.clinbiochem.2007.08.004Search in Google Scholar

4. Darby WJ, Bridgforth E, le Brocquy J, Clark Jr SL, de Oliveira JD, Kevany J, et al. Vitamin B12 requirement of adult man. Am J Med 1958;25:726–32.10.1016/0002-9343(58)90010-XSearch in Google Scholar

5. Carmel R, Brar S, Agrawal A, Penha PD. Failure of assay to identify low cobalamin concentrations. Clin Chem 2000;46:2017–8.10.1093/clinchem/46.12.2017Search in Google Scholar

6. Lamers Y. Indicators and methods for folate, vitamin B-12, and vitamin B-6 status assessment in humans. Curr Opin Clin Nutr Metab Care 2011;14:445–54.10.1097/MCO.0b013e328349f9a7Search in Google Scholar PubMed

7. Iqtidar N, Chaudary MN. Misdiagnosed vitamin B12 deficiency a challenge to be confronted by use of modern screening markers. J Pak Med Assoc 2012;62:1223–9.Search in Google Scholar

8. Stabler SP. Vitamin B12 deficiency. N Engl J Med 2013;368: 149–60.10.1056/NEJMcp1113996Search in Google Scholar PubMed

9. Blom HJ, van Rooij A, Hogeveen M. A simple high-throughput method for the determination of plasma methylmalonic acid by liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2007;45:645–50.10.1515/CCLM.2007.117Search in Google Scholar PubMed

10. Bock JL, Eckfeldt JH. Advances in standardization of laboratory measurement procedures: implications for measuring biomarkers of folate and vitamin B-12 status in NHANES. Am J Clin Nutr 2011;94:332S–6S.10.3945/ajcn.111.013359Search in Google Scholar PubMed PubMed Central

11. Thorpe SJ, Heath A, Blackmore S, Lee A, Hamilton M, O’Broin S, et al. International standard for serum vitamin B12 and serum folate: international collaborative study to evaluate a batch of lyophilised serum for B12 and folate content. Clin Chem Lab Med 2007;45:380–6.10.1515/CCLM.2007.072Search in Google Scholar PubMed

12. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 2005;105: 978–85.10.1182/blood-2004-04-1641Search in Google Scholar PubMed

13. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol 1990;34:99–107.10.1002/ajh.2830340205Search in Google Scholar PubMed

14. Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C. Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic elderly population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr 1999;70:904–10.10.1093/ajcn/70.5.904Search in Google Scholar PubMed

15. Pitkin R, Allen L, Bailey L, Bernfield M. Vitamin B12. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin and choline. Washington, DC: National Academy Press, 2000:306–56.Search in Google Scholar

Received: 2014-8-21
Accepted: 2014-12-1
Published Online: 2015-1-20
Published in Print: 2015-7-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Once upon a time: a tale of ISO 15189 accreditation
  4. A new integrated tool for assessing and monitoring test comparability and stability
  5. Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests
  6. Reviews
  7. Thromboembolic risk in hematological malignancies
  8. A review of the cut-off points for the diagnosis of vitamin B12 deficiency in the general population
  9. Opinion Paper
  10. Permissible limits for uncertainty of measurement in laboratory medicine
  11. EFLM Position Paper
  12. Flexible scope for ISO 15189 accreditation: a guidance prepared by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group Accreditation and ISO/CEN standards (WG-A/ISO)
  13. Genetics and Molecular Diagnostics
  14. Evaluation of a low-cost procedure for sampling, long-term storage, and extraction of RNA from blood for qPCR analyses
  15. Application of real-time PCR of sex-independent insertion-deletion polymorphisms to determine fetal sex using cell-free fetal DNA from maternal plasma
  16. General Clinical Chemistry and Laboratory Medicine
  17. The Empower project – a new way of assessing and monitoring test comparability and stability
  18. Comparison of four automated serum vitamin B12 assays
  19. Combined indicator of vitamin B12 status: modification for missing biomarkers and folate status and recommendations for revised cut-points
  20. INR vs. thrombin generation assays for guiding VKA reversal: a retrospective comparison
  21. Determination of dabigatran in plasma, serum, and urine samples: comparison of six methods
  22. Simple high-throughput analytical method using ultra-performance liquid chromatography coupled with tandem mass spectrometry to quantify total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine
  23. Revival of physostigmine – a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients
  24. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome
  25. Reference Values and Biological Variations
  26. Relevance of EDTA carryover during blood collection
  27. Reference intervals for renal injury biomarkers neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in young infants
  28. Cardiovascular Diseases
  29. NT-proBNP levels and their relationship with systemic ventricular impairment in adult patients with transposition of the great arteries long after Mustard or Senning procedure
  30. Letters to the Editors
  31. Troponin T measured with highly sensitive assay (hsTnT) on admission does not reflect infarct size in ST-elevation myocardial infarction patients receiving primary percutaneous coronary intervention
  32. Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer’s disease
  33. Serum brain injury biomarkers as predictors of mortality after severe aneurysmal subarachnoid hemorrhage: preliminary results
  34. Tumor markers assay by the Lumipulse G
  35. Real-world costs of laboratory tests for non-small cell lung cancer
  36. Impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein
  37. Practicability of fetal scalp blood sampling during labor using microtubes and a point-of-care (POC) lactate testing device: difficulty assessment, sampling time and failure rates
  38. Establishing objective analytical quality requirements in the IgE specific assay: a message in a bottle
  39. Bacteria on a peripheral blood smear as presenting sign of overwhelming post-splenectomy infection in a patient with secondary acute myeloid leukemia
Downloaded on 1.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0843/html
Scroll to top button